Incidencia de infecciones de transmisión sexual y modelos de cribado entre usuarios de profilaxis preexposición frente al VIH

IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES
Oskar Ayerdi , Eva Orviz , Adrián Valls Carbó , Nuria Fernández Piñeiro , Mar Vera García , Teresa Puerta López , Juan Ballesteros Martín , Carmen Rodríguez Martín , Begoña Baza Caraciolo , Clara Lejarraga Cañas , Jorge-Alfredo Pérez-García , Dulce Carrió , Mónica García Lotero , María Ferreras Forcada , Montserrat González Polo , Montserrat Raposo Utrilla , Alberto Delgado-Iribarren , Jorge Del Romero-Guerrero , Vicente Estrada Pérez
{"title":"Incidencia de infecciones de transmisión sexual y modelos de cribado entre usuarios de profilaxis preexposición frente al VIH","authors":"Oskar Ayerdi ,&nbsp;Eva Orviz ,&nbsp;Adrián Valls Carbó ,&nbsp;Nuria Fernández Piñeiro ,&nbsp;Mar Vera García ,&nbsp;Teresa Puerta López ,&nbsp;Juan Ballesteros Martín ,&nbsp;Carmen Rodríguez Martín ,&nbsp;Begoña Baza Caraciolo ,&nbsp;Clara Lejarraga Cañas ,&nbsp;Jorge-Alfredo Pérez-García ,&nbsp;Dulce Carrió ,&nbsp;Mónica García Lotero ,&nbsp;María Ferreras Forcada ,&nbsp;Montserrat González Polo ,&nbsp;Montserrat Raposo Utrilla ,&nbsp;Alberto Delgado-Iribarren ,&nbsp;Jorge Del Romero-Guerrero ,&nbsp;Vicente Estrada Pérez","doi":"10.1016/j.eimc.2024.01.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>There is discussion about the frequency of STI screening among pre-exposure prophylaxis (PrEP) users. The aim of this study was to analyze the incidence of STIs and to evaluate different screening models in order to optimize the follow-up.</div></div><div><h3>Methodology</h3><div>A prospective study was conducted between 2017 and 2023, including 138 PrEP users in a STI clinic. Participants were tested for STIs every three months. Unscheduled visits were performed for those with STI-related symptoms or for people who were notified for an STI by a sexual partner. We performed a survival analysis of repeated events, estimating the cumulative incidence (<span>C</span>I) and incidence rate (IR).</div></div><div><h3>Results</h3><div>The overall CI by quarterly screening was 8.3 (95% CI: 7.6–9.1) infections per person over six years, with a decreasing trend. The most frequently diagnosed pathogen was <em>Neisseria gonorrhoeae</em>, with a IR of 0.76 (95% CI: 0.68–0.84). If the frequency of screening is reduced to every six months, the IR of STIs is reduced by (95% CI: 0.5–0.66) infections per user per year, and at 12 months by 0.82 (95% CI: 0.73–0.89). In the case of no pharyngeal or urethral screening, IR is reduced by 0.37 (95% CI: 0.32–0.42) infections per person per year and in those over 35 years of age by 0.33 (95% CI: 0.25–0.4). Eliminating unscheduled visits, the reduction in IR is 0.33 (95% CI: 0.24–0.42).</div></div><div><h3>Conclusions</h3><div>The incidence of STIs among PrEP users is high, especially in the rectum, but it does not increase over time. STI screening could be optimized reducing the frequency of pharyngeal and urethral testing, particularly in those over 35 years of age. It is essential to redistribute health resources for unscheduled visits, which have been shown to be the most cost-effective screening.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 10","pages":"Pages 570-576"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X24001903","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

There is discussion about the frequency of STI screening among pre-exposure prophylaxis (PrEP) users. The aim of this study was to analyze the incidence of STIs and to evaluate different screening models in order to optimize the follow-up.

Methodology

A prospective study was conducted between 2017 and 2023, including 138 PrEP users in a STI clinic. Participants were tested for STIs every three months. Unscheduled visits were performed for those with STI-related symptoms or for people who were notified for an STI by a sexual partner. We performed a survival analysis of repeated events, estimating the cumulative incidence (CI) and incidence rate (IR).

Results

The overall CI by quarterly screening was 8.3 (95% CI: 7.6–9.1) infections per person over six years, with a decreasing trend. The most frequently diagnosed pathogen was Neisseria gonorrhoeae, with a IR of 0.76 (95% CI: 0.68–0.84). If the frequency of screening is reduced to every six months, the IR of STIs is reduced by (95% CI: 0.5–0.66) infections per user per year, and at 12 months by 0.82 (95% CI: 0.73–0.89). In the case of no pharyngeal or urethral screening, IR is reduced by 0.37 (95% CI: 0.32–0.42) infections per person per year and in those over 35 years of age by 0.33 (95% CI: 0.25–0.4). Eliminating unscheduled visits, the reduction in IR is 0.33 (95% CI: 0.24–0.42).

Conclusions

The incidence of STIs among PrEP users is high, especially in the rectum, but it does not increase over time. STI screening could be optimized reducing the frequency of pharyngeal and urethral testing, particularly in those over 35 years of age. It is essential to redistribute health resources for unscheduled visits, which have been shown to be the most cost-effective screening.
艾滋病毒暴露前预防疗法(PrEP)使用者的性传播感染发病率和筛查模式
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
8.00%
发文量
194
审稿时长
29 days
期刊介绍: Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信